Abstract
The effect of adenosine on Na+/H+ exchange activity was examined in cultured A6 renal epithelial cells. Adenosine and its analogue N6-cyclopentyladenosine (CPA) had different effects on Na+/H+ exchange activity depending on the side of addition. Basolateral CPA induced a stimulation of Na+/H+ exchange activity that was completely prevented by preincubation with an A2A-selective antagonist, 8-(3-chlorostyryl)caffeine, whereas apical CPA induced a slight but significant inhibition of Na+/H+ exchange activity that was significantly reduced by the A1-receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine. Protein kinase C activation may be involved in mediating the apical CPA inhibition of Na+/H+ exchange activity; this inhibition was prevented by the protein kinase C inhibitor calphostin C. Treatment with either forskolin or 8-bromo-cAMP significantly stimulated Na+/H+ exchange activity; only basolateral CPA addition induced an increase in cAMP level. These observations together with the finding that the CPA-dependent stimulation of exchange activity was prevented by the protein kinase A inhibitor H-89 support the hypothesis that basolateral CPA stimulates Na+/H+ exchange via adenylate cyclase/protein kinase A activation. Basolateral CPA also increased transepithelial Na+ transport, and this stimulation was prevented by the Na+/H+ exchange inhibitor HOE-694, suggesting that changes in pHi during hormone action can act as an intermediate in the second-messenger cascade.
Footnotes
-
Address correspondence to: Dr. Valeria Casavola, Institute of General Physiology, University of Bari, Via Amendola 165/A, 70126 Bari, Italy. E-mail:casavola{at}bioserver.uniba.it
-
This work was supported by a Consiglio Nazionale delle Ricerche Bilateral Italy-Switzerland Grant.
- Abbreviations:
- pHi
- intracellular pH
- CPA
- N6-cyclopentyladenosine
- BCECF
- 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein
- DPMA
- N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine
- HOE-694
- (3-methylsulfonyl-4-piperidino-benzoyl)guanidine methanesulfonate
- H-89
- N-[2-(p-bromocinnamylamino)ethyl]5-isoquinolinesulfonamide
- TPA
- phorbol-12-myristate-13-acetate
- TMA
- tetramethylammonium
- CSC
- 8-(3-chlorostyryl)caffeine
- CPX
- 1,3-dipropyl-8-cyclopentylxanthine
- PKC
- protein kinase C
- PKA
- protein kinase A
- Isc
- short circuit current
- EGTA
- ethylene glycol bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
- HEPES
- 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
- Received July 26, 1996.
- Accepted December 4, 1996.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|